newsfilter
← Latest News
GlobeNewswire·

Virtuix Signs Strategic Partnership with Sirica Therapeutics to Advance AI-Driven Autism Therapy

  • Virtuix Holdings Inc. (NASDAQ: VTIX) announced a strategic partnership with Sirica Therapeutics to deploy Omni One systems for immersive autism therapy.
  • The first two Omni One systems were sold & shipped to Sirica's treatment center in the San Francisco Bay Area.
  • The collaboration aims to use movement-centered virtual reality & AI-assisted experiences to enhance engagement & treatment outcomes for children with autism.
  • Sirica plans to establish approximately 100 specialized treatment centers across the United States.
  • The partnership builds on prior research collaborations between Virtuix & Rutgers University regarding AI-assisted neurodivergent therapy.
  • Virtuix also previously collaborated with Florida Gulf Coast University to utilize Omni One for neurological rehabilitation.
  • Sirica's COSMO therapy model combines purposeful movement, sensory engagement, & cognitive challenges to improve quality of life outcomes.
  • Virtuix's technology enables natural user movements such as walking, running, crouching, kneeling, & turning within a compact footprint.
  • The companies intend to expand the use of immersive technology into clinical environments for behavioral health applications.